Home›Companies›Biotech & Pharma›Astek Diagnostics

Astek Diagnostics, Inc.

Updated Oct 27, 2026·Latest SEC filing Apr 28, 2025·Suggest an edit

About Astek Diagnostics

Astek Diagnostics is a private company based in Halethorpe, Maryland, incorporated in 2021 in Delaware. It has reported $4,150,000 raised in six offerings on Form D since August 2023. Its chief executive is Mustafa Al-Adhami.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 4, 2025Apr 28, 2025$750,000of $1.5M target2$375KSecurities on exerciseRule 506(b)Form D ↗
Oct 1, 2023Oct 19, 2023$1,150,000of $2.5M target4$287KSecurities on exerciseRule 506(b)Form D ↗
Dec 22, 2022Aug 28, 2023$350,000fully sold2$175KSecurities on exerciseRule 506(b)Form D ↗
Jun 16, 2020Aug 28, 2023$150,000fully sold1$150KSecurities on exerciseRule 506(b)Form D ↗
Jul 30, 2021Aug 28, 2023$345,000fully sold10$34,500Securities on exerciseRule 506(b)Form D ↗
Mar 22, 2023Apr 5, 2023amended Aug 28, 2023$1,405,000of $2.0M target11$127KSecurities on exerciseRule 506(b)Form D/A ↗2 earlier filings
Total, six offerings$4,150,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Astek Diagnostics's Form D filed Apr 28, 2025.

MA
Mustafa Al-Adhami
President/CEO and director

Sources

  1. SECAstek Diagnostics, Inc. Form D/A, filed Jun 8, 2023
  2. SECAstek Diagnostics, Inc. Form D, filed Apr 5, 2023
  3. SECAstek Diagnostics, Inc. filing history